Found: 37
Select item for more details and to access through your institution.
Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2–positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study).
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 1, p. 217, doi. 10.1007/s10637-020-00991-6
- By:
- Publication type:
- Article
Safety and effectiveness of eribulin in Japanese patients with locally advanced or metastatic breast cancer: a post-marketing observational study.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 6, p. 791, doi. 10.1007/s10637-017-0486-4
- By:
- Publication type:
- Article
A Retrospective Study of the Novel Combination of Paclitaxel and S1 for Pretreated Advanced Non-Small Cell Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2013, v. 58, n. 6, p. 454, doi. 10.1159/000345624
- By:
- Publication type:
- Article
Phase II trial of biweekly administration with eribulin after three cycles of induction therapy in hormone receptor-positive, HER2-negative metastatic breast cancer (JACCRO BC-03).
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 201, n. 3, p. 409, doi. 10.1007/s10549-023-07030-x
- By:
- Publication type:
- Article
Real-world data analysis of perioperative chemotherapy patterns, G-CSF use, and FN status in patients with early breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 201, n. 2, p. 265, doi. 10.1007/s10549-023-07015-w
- By:
- Publication type:
- Article
Prognostic value of serum tartrate‑resistant acid phosphatase‑5b for bone metastasis in patients with resectable breast cancer.
- Published in:
- Oncology Letters, 2024, v. 27, n. 6, p. N.PAG, doi. 10.3892/ol.2024.14383
- By:
- Publication type:
- Article
Evaluation of RASSF1A methylation in the lysate of sentinel lymph nodes for detecting breast cancer metastasis: A diagnostic accuracy study.
- Published in:
- Oncology Letters, 2023, v. 26, n. 5, p. 1, doi. 10.3892/ol.2023.14063
- By:
- Publication type:
- Article
Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer in the first-line or second-line setting: an observational study
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 4, p. 621, doi. 10.1007/s12282-024-01575-5
- By:
- Publication type:
- Article
Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
STK11 loss drives rapid progression in a breast cancer patient resulting in pulmonary tumor thrombotic microangiopathy.
- Published in:
- Breast Cancer (13406868), 2021, v. 28, n. 3, p. 765, doi. 10.1007/s12282-020-01200-1
- By:
- Publication type:
- Article
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.
- Published in:
- Breast Cancer (13406868), 2020, v. 27, n. 3, p. 322, doi. 10.1007/s12282-020-01085-0
- By:
- Publication type:
- Article
Dose-dense adjuvant chemotherapy: a systematic review and meta-analysis of the Japanese Breast Cancer Society Clinical Practice Guideline, 2018 edition.
- Published in:
- Breast Cancer (13406868), 2020, v. 27, n. 3, p. 334, doi. 10.1007/s12282-019-01039-1
- By:
- Publication type:
- Article
Aldehyde dehydrogenase 2 genotype in tolerability of alcohol contained in paclitaxel in Japanese breast cancer patients.
- Published in:
- Breast Cancer (13406868), 2019, v. 26, n. 2, p. 229, doi. 10.1007/s12282-018-0918-9
- By:
- Publication type:
- Article
Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 4, p. 438, doi. 10.1007/s12282-018-0843-y
- By:
- Publication type:
- Article
Efficacy and safety of re-induction therapy with bevacizumab and paclitaxel for metastatic breast cancer.
- Published in:
- Breast Cancer (13406868), 2017, v. 24, n. 1, p. 147, doi. 10.1007/s12282-016-0686-3
- By:
- Publication type:
- Article
Phase II study of neoadjuvant anastrozole and concurrent radiotherapy for postmenopausal breast cancer patients.
- Published in:
- Breast Cancer (13406868), 2014, v. 21, n. 5, p. 550, doi. 10.1007/s12282-012-0426-2
- By:
- Publication type:
- Article
Real-world effectiveness of post-trastuzumab emtansine treatment in patients with HER2-positive, unresectable and/or metastatic breast cancer: a retrospective observational study (KBCSG-TR 1917).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effectiveness and safety of primary prophylaxis with G-CSF for patients with Ewing sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1081, doi. 10.1007/s10147-024-02572-6
- By:
- Publication type:
- Article
Effectiveness and safety of primary prophylaxis with G-CSF during chemotherapy for invasive breast cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the Use of G-CSF 2022.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1074, doi. 10.1007/s10147-024-02570-8
- By:
- Publication type:
- Article
Primary prophylaxis with G-CSF for patients with non-round cell soft tissue sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1067, doi. 10.1007/s10147-024-02569-1
- By:
- Publication type:
- Article
Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 899, doi. 10.1007/s10147-023-02461-4
- By:
- Publication type:
- Article
Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 700, doi. 10.1007/s10147-024-02541-z
- By:
- Publication type:
- Article
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 681, doi. 10.1007/s10147-024-02504-4
- By:
- Publication type:
- Article
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 689, doi. 10.1007/s10147-024-02502-6
- By:
- Publication type:
- Article
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 559, doi. 10.1007/s10147-024-02501-7
- By:
- Publication type:
- Article
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 551, doi. 10.1007/s10147-024-02499-y
- By:
- Publication type:
- Article
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 545, doi. 10.1007/s10147-024-02491-6
- By:
- Publication type:
- Article
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 355, doi. 10.1007/s10147-024-02469-4
- By:
- Publication type:
- Article
Hypercalcemia affected in metastatic breast cancer patients without bone metastasis: report of three cases.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
A case of sternal osteomyelitis during treatment with everolimus for recurrent breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Epstein-Barr virus-associated post-transplant lymphoproliferative disorders after allogeneic peripheral blood stem cell transplantation for Hodgkin-like adult T-cell leukemia/lymphoma.
- Published in:
- 2012
- By:
- Publication type:
- Report
High HER2 Intratumoral Heterogeneity Is a Predictive Factor for Poor Prognosis in Early-Stage and Locally Advanced HER2-Positive Breast Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 1062, doi. 10.3390/cancers16051062
- By:
- Publication type:
- Article
Detection of Ultra-Rare ESR1 Mutations in Primary Breast Cancer Using LNA-Clamp ddPCR.
- Published in:
- Cancers, 2023, v. 15, n. 9, p. 2632, doi. 10.3390/cancers15092632
- By:
- Publication type:
- Article
Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4399, doi. 10.3390/cancers13174399
- By:
- Publication type:
- Article
Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prevalence of BRCA1 and BRCA2 mutations in Japanese patients with triple-negative breast cancer: A single institute retrospective study.
- Published in:
- Molecular & Clinical Oncology, 2021, v. 14, n. 5, p. N.PAG, doi. 10.3892/mco.2021.2258
- By:
- Publication type:
- Article
Pertuzumab retreatment for HER2‐positive advanced breast cancer: A randomized, open‐label phase III study (PRECIOUS).
- Published in:
- Cancer Science, 2022, v. 113, n. 9, p. 3169, doi. 10.1111/cas.15474
- By:
- Publication type:
- Article